List all gene expressions in dataset HuLDa00010. The number is 3692.
First page Previous Next Last pageGene name |
Dataset name |
Gene expression |
ATP-binding cassette, sub-family A (ABC1), member 13 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
v-abl Abelson murine leukemia viral oncogene homolog 2 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
actin-binding Rho activating protein | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
acyl-CoA binding domain containing 3 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
acyl-CoA binding domain containing 6 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
acid phosphatase 6, lysophosphatidic | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
actin, alpha 1, skeletal muscle | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
actinin, alpha 2 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ADAM metallopeptidase domain 15 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ADAM metallopeptidase with thrombospondin type 1 motif, 12 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ADAMTS-like 4 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenosine deaminase, RNA-specific | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
aarF domain containing kinase 5 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenylate cyclase 10 (soluble) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenylate cyclase 2 (brain) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenylate cyclase 8 (brain) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |